about
Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A reviewRisk of acute myocardial infarction after transurethral resection of prostate in elderlyOral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysisPrognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart FailureInstruments for geriatric assessment: new multidimensional assessment approaches.β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?Molecular aspects of the cardioprotective effect of exercise in the elderly.Effects of exercise training on cardiovascular adrenergic system.The lipid theory in the pathogenesis of calcific aortic stenosis.Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure.Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure.Increased Epicardial Adipose Tissue Volume Correlates With Cardiac Sympathetic Denervation in Patients With Heart Failure.Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease.Speckle-tracking analysis based on 2D echocardiography does not reliably measure left ventricular torsion.Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy.Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis.Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical caseErratum: Impact of bivalirudin and genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndromeImpact of bivaluridin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndromeAortic Valve Sclerosis in Patients with Peripheral and/or Coronary Arterial DiseaseMyocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis
P50
Q26827939-F0A23C15-3E42-4289-BA5E-71F287A99F6AQ26859700-9DBA25B0-E5B5-49FB-BFF4-130F14DA015EQ28484769-2E1E8BE5-25B4-4F97-A844-8A2F98F801EFQ36757784-AEE7B378-8701-40C5-AAD1-079DE1E47FDBQ38019856-25A6B4DB-F93A-45BD-843C-794ACA37FF7AQ38064688-C9A11FDB-7E4A-4066-A604-B536DBB0A7C1Q38129354-2D8CBAEC-3F3A-40FD-9884-8D3FFDFD1D55Q38172127-5FD8B880-107E-4E84-A2C1-577CC61828AFQ38393667-6D515EEE-46C4-43D6-9AAB-6237C8CA6C53Q39658039-4F591F56-B3BF-4463-87EA-F52A02E3C50FQ39692006-38CF8831-51E3-4822-9F99-64EB360C5746Q39959976-E8EA7129-06AC-46D2-BEB0-A7E1619E3F5BQ40968701-EFEDD4CA-20E5-4BCA-B2ED-E9871F9F8214Q43969218-C9C75136-9661-4025-B16A-FC0A5C6DCCC6Q44533259-67A7D83F-8AB1-42B6-895A-483F2826ADBEQ44611850-563C129B-CDD8-419D-AEE4-7E5B9A6C92DFQ44762347-A25F9792-400E-4D20-BC88-9C86B48AF067Q46169082-5680CCAE-711E-4CC5-955B-D8BD4B76C8EDQ50978052-3C53D37B-C9CF-404A-904B-C8B4B85BCF59Q53566054-9413B71F-2D46-48E2-A649-12C1A371D6CAQ57618847-D9B21A40-E092-4936-A114-2753C110BD4AQ59695693-ACE4650E-7C05-46C2-BF7B-D626683DA014Q59695719-158908A8-2B2E-435A-9647-F92EE54CFC22Q59695731-1EC31B0F-D249-4235-8007-AA7B1B6D2438Q59695734-DD1B9D55-3015-4464-B0DF-98C9C7BDB85C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valentina Parisi
@ast
Valentina Parisi
@en
Valentina Parisi
@es
Valentina Parisi
@nl
Valentina Parisi
@sl
type
label
Valentina Parisi
@ast
Valentina Parisi
@en
Valentina Parisi
@es
Valentina Parisi
@nl
Valentina Parisi
@sl
prefLabel
Valentina Parisi
@ast
Valentina Parisi
@en
Valentina Parisi
@es
Valentina Parisi
@nl
Valentina Parisi
@sl
P106
P1153
7005320759
P21
P31
P496
0000-0003-4614-474X